Rachel S Greenberg1, Hegang Chen, Jeffrey D Hasday. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore VA Medical Center, Baltimore, MD 21201, USA.
Abstract
PURPOSE: Fever occurs commonly in the critically ill patients and may adversely affect outcome. Acetaminophen is one of the most commonly used antipyretic agents in the intensive care unit; however, there is little evidence that it is effective in this population. The objective of this study was to analyze the antipyretic activity of acetaminophen in critically ill patients. MATERIALS AND METHODS: We performed a retrospective study of medical intensive care unit and surgical intensive care unit patients with systemic inflammatory response syndrome and compared the resolution of fever in the presence and absence of acetaminophen treatment by comparing the absolute reduction in body temperature and the rate of cooling over comparable time frames in fevers that were untreated and those treated with acetaminophen. RESULTS: We analyzed 166 febrile episodes (body temperature, >38 degrees C) in 59 patients with systemic inflammatory response syndrome without cancer, neurologic disease, or liver disease. Acetaminophen was administered for 88 of 166 fevers. Febrile episodes in which other antipyretic drugs or external cooling were administered were excluded. The response to acetaminophen was variable, but the absolute temperature reduction was slightly higher (mean, 0.86 versus 0.56 degrees C; P = .0362), and the cooling rate was slightly more rapid (mean, 0.20 versus 0.13 degrees C per hour; P = .0152) in acetaminophen-treated versus untreated fevers. There were no obvious differences between the most and least responsive patients. CONCLUSIONS: We conclude that acetaminophen has significant albeit modest antipyretic activity in critically ill patients. Copyright (c) 2010 Elsevier Inc. All rights reserved.
PURPOSE:Fever occurs commonly in the critically ill patients and may adversely affect outcome. Acetaminophen is one of the most commonly used antipyretic agents in the intensive care unit; however, there is little evidence that it is effective in this population. The objective of this study was to analyze the antipyretic activity of acetaminophen in critically ill patients. MATERIALS AND METHODS: We performed a retrospective study of medical intensive care unit and surgical intensive care unit patients with systemic inflammatory response syndrome and compared the resolution of fever in the presence and absence of acetaminophen treatment by comparing the absolute reduction in body temperature and the rate of cooling over comparable time frames in fevers that were untreated and those treated with acetaminophen. RESULTS: We analyzed 166 febrile episodes (body temperature, >38 degrees C) in 59 patients with systemic inflammatory response syndrome without cancer, neurologic disease, or liver disease. Acetaminophen was administered for 88 of 166 fevers. Febrile episodes in which other antipyretic drugs or external cooling were administered were excluded. The response to acetaminophen was variable, but the absolute temperature reduction was slightly higher (mean, 0.86 versus 0.56 degrees C; P = .0362), and the cooling rate was slightly more rapid (mean, 0.20 versus 0.13 degrees C per hour; P = .0152) in acetaminophen-treated versus untreated fevers. There were no obvious differences between the most and least responsive patients. CONCLUSIONS: We conclude that acetaminophen has significant albeit modest antipyretic activity in critically ill patients. Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: Carl I Schulman; Nicholas Namias; James Doherty; Ronald J Manning; Pamela Li; Pam Li; Ahmed Elhaddad; Ahmed Alhaddad; David Lasko; Jose Amortegui; Christopher J Dy; Lucie Dlugasch; Gio Baracco; Stephen M Cohn Journal: Surg Infect (Larchmt) Date: 2005 Impact factor: 2.150
Authors: P A Gross; T L Barrett; E P Dellinger; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel Journal: Clin Infect Dis Date: 1994-03 Impact factor: 9.079
Authors: G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell Journal: N Engl J Med Date: 1997-03-27 Impact factor: 91.245
Authors: Jeffrey D Hasday; Allen Garrison; Ishwar S Singh; Theodore Standiford; Garrettson S Ellis; Srinivas Rao; Ju-Ren He; Penny Rice; Mariah Frank; Simeon E Goldblum; Rose M Viscardi Journal: Am J Pathol Date: 2003-06 Impact factor: 4.307
Authors: C A Manthous; J B Hall; D Olson; M Singh; W Chatila; A Pohlman; R Kushner; G A Schmidt; L D Wood Journal: Am J Respir Crit Care Med Date: 1995-01 Impact factor: 21.405
Authors: Nicholas M Mohr; Brian M Fuller; Lee P Skrupky; Hawnwan Moy; Robert Alunday; Scott T Micek; Richard E Fagley Journal: Ann Pharmacother Date: 2011-09-20 Impact factor: 3.154
Authors: Giora Netzer; David W Dowdy; Thelma Harrington; Satish Chandolu; Victor D Dinglas; Nirav G Shah; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl Shanholtz; Jeffrey D Hasday; Dale M Needham Journal: Ann Am Thorac Soc Date: 2013-12
Authors: Nirav G Shah; Mark J Cowan; Edward Pickering; Houtan Sareh; Majid Afshar; Dawn Fox; Jennifer Marron; Jennifer Davis; Keith Herold; Carl B Shanholtz; Jeffrey D Hasday Journal: J Crit Care Date: 2012-07-02 Impact factor: 3.425
Authors: Nicholas Mohr; Lee Skrupky; Brian Fuller; Hawnwan Moy; Robert Alunday; Michael Wallendorf; Scott Micek; Richard Fagley Journal: Intern Emerg Med Date: 2012-08-28 Impact factor: 3.397